Connect with us

Newsletter

Stock Price Newsletter – Breaking News & Articles For March 20, 2019

Joe Samuel

Published

on

Premier Health (OTC:P​HGRF) (CSE:P​HGI) Launching Virtual and Remote Medical Services

VANCOUVER, British Columbia, March 20, 2019 (GLOBE NEWSWIRE) — Premier Health Group (CSE: PHGI, OTCQB: PHGRF, Frankfurt: 6PH) (the “Company” or “Premier Health”), a Company focused on developing innovative approaches that combine human skill-based expertise with emerging technologies for the healthcare industry, is pleased to announce it will be launching a range of virtual and remote services to be offered to primary care clinics, including Nurses,  Medical Office Assistants (MOA) and Office Managers. The initial launch will focus on current Juno EMR clients in BC with plans to roll out to other provinces by the end of Q2 2019. Click Here And Read The Full Press Release

Where Is Healthcare Headed?

As the global population begins to both increase in number and age, more and more people are in need of personalized healthcare and treatment tailored to their specific needs. Diseases have become far too advanced for patients to take a “one-pill-cures-all” treatment and hope for the best. Medical experts and scientists are actually looking at a patient’s genetic makeup to determine how to best treat each individual person.  Click Here To Read More

Google Stadia Is More Than It Streams

Moving on, it’s safe to say that there are few, if any, people in the world that haven’t heard of Google (GOOGL). The Company created a search engine which has since revolutionized how we ascertain information, as well as how businesses reach out to consumers. During that time, Google (GOOGL) has been given a home in the Oxford English Dictionary, as well as expanded its operations to far more than an internet-powered encyclopedia on everything anyone could ever know. We’ve seen Google Maps (GOOGL), Google’s own smartphone, the Pixel, and countless other innovations from the gargantuan tech company.  Read More Here.


 

Disclaimer: Pursuant to an agreement between MIDAM VENTURES, LLC  and Premier Health Group Inc. we were hired for a period from 10/1/2018 – 4/1/2019 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. We were paid $300,000 (CASH) for & were paid “500,000” shares of restricted common shares (as of 1/2/2019). Midam has been compensated an additional $100,000 by Premier Health Group to extend the period of coverage to June 1, 2019. We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6) Six-month restriction is complete on 4/1/2019 we plan to sell the “500,000” shares of Premier Health Group Inc. that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Click Here For Full Disclaimer.

Continue Reading
Click to comment

Featured

Stock Price Newsletter – September 18, 2019

Joe Samuel

Published

on

biotech stock to watch 2019

4 Penny Stocks Catching Attention This Week

Several economic and sector events have sparked interest in a number of small-cap and micro-cap stocks this week.

See For Yourself


Airline Stocks In Focus; Spur Interest In Detection Tech Companies?

The latest mix of attacks and focus on airlines could have a different impact on sectors like weapons detection & defense. What could this mean for stocks to watch this week?

Click Here To Read More


Top Biotech Stocks To Watch This Week

The values of biotech equities, however, do generally start to pick up as the year winds down. The underlying reason is that the latter part of the year is chock-full of key data readouts, regulatory decisions, and thousands of scientific conferences across the globe. 

Click Here To Read More

Click Here For Full Disclaimer

Continue Reading

Featured

Stock Price Newsletter – September 17, 2019

Joe Samuel

Published

on

stock market news

A Billion Dollar Industry Disruptor?

There have been more mass shootings this year in the United States than there have been days in the year. This is becoming a huge issue that is costing precious lives and could see billions of dollars spent to fix this situation. One company has a technology product that could disrupt this multi-billion-dollar industry for the better.

Click To Read More


Top 4 Penny Stocks To Watch This Week

Penny stocks are some of the most active and volatile types of stocks in the stock market today. But what everyone knows about these is that they can break out in a big way. That’s why so many continue to look for the best penny stocks to buy. In this regard, several economic and sector events have sparked interest in a number of small-cap and micro-cap stocks this week.

Continue Reading


3 Biotech Stocks Jumped Big Last Month

Plenty of companies are doing revolutionary work in this space and have the potential of turning into excellent investments eventually. Here is a look at 3 biotech stocks that jumped significantly over the past few weeks and deserve to be on the watch lists of investors.

Click Here To Read More

Continue Reading

Featured

Stock Price Newsletter – September 16, 2019

A. Lawrence

Published

on

stock market today

Tiziana Life Sciences (TLSA) Announces FDA Approval to Initiate Phase I Clinical Trial with Orally Administered Foralumab in Healthy Volunteers

Tiziana Life Sciences plc (NASDAQ:TLSA and AIM: TILS), a clinical stage biotechnology company focused on developing targeted drugs for cancer and inflammatory diseases, is pleased to announce (further to the announcement made on 1 May 2019) that the U.S. Food and Drug Administration (FDA) has allowed the initiation of a Phase I clinical trial in healthy volunteers using a novel oral enteric-coated capsule formulation of Foralumab, a fully human monoclonal antibody (mAb), in collaboration with the Brigham and Women’s Hospital (BWH), Harvard Medical School, Boston, MA.

Continue Reading


Are Biotech Stocks Setting The Stage For Another Bull Trend?

Biotech stocks and the biotech sector have proven to be one of the fastest-growing sectors over the last decade. According to most experts, it is expected to continue in the same vein in the foreseeable future. What could be in store?

See For Yourself


Over 330 Mass Shootings!

There have been more mass shootings this year in the United States than there have been days in the year. This is becoming a huge issue that is costing precious lives and could see billions of dollars spent to fix this situation. One company has a technology product that could disrupt this multi-billion-dollar industry for the better.

Click To Read More

Continue Reading

Join Our Newsletter

Get stock alerts, news & trending stock alerts straight to your inbox!


Privacy Policy

We keep all user information pricate & promise to never spam.*

Stock Price Free Text List

Search Stock Price (StockPrice.com)




Trending

Subscribe Now & Begin Receiving Free Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Stock Market & Finance, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on stock market & finance related, articles, news and trade alerts. Further questions please contact privacy@stockprice.com